Get started
Author

Anjan K. Chakrabarti

Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity
2004 · Sanjay Rajagopalan, Emily C. Somers, et al. · Blood · 255
Benefit of Transferring ST-Segment–Elevation Myocardial Infarction Patients for Percutaneous Coronary Intervention Compared With Administration of Onsite Fibrinolytic Declines as Delays Increase
2011 · Duane S. Pinto, Paul D. Frederick, et al. · Circulation · 195
EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention
2015 · C. Michael Gibson, Robert P. Giugliano, et al. · European Heart Journal · 162
Mechanical Circulatory Support for Right Ventricular Failure
2013 · Navin K. Kapur, Vikram Paruchuri, et al. · JACC Heart Failure · 130
PDF
Altered cutaneous microvascular responses to reactive hyperaemia in coronary artery disease: a comparative study with conduit vessel responses
2002 · Qurratul Aine SHAMIM-UZZAMAN, Dana PFENNINGER, et al. · Clinical Science · 107
Reduction of Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Rivaroxaban in ATLAS-ACS 2 TIMI 51
2013 · C. Michael Gibson, Anjan K. Chakrabarti, et al. · Journal of the American College of Cardiology · 103
PDF
Time-to-Reperfusion in Patients Undergoing Interhospital Transfer for Primary Percutaneous Coronary Intervention in the U.S
2008 · Anjan Chakrabarti, Harlan M. Krumholz, et al. · Journal of the American College of Cardiology · 100
PDF
Rapid-onset endothelial dysfunction with adriamycin: evidence for a dysfunctional nitric oxide synthase
2003 · Damon Duquaine, Glenn A Hirsch, et al. · Vascular Medicine · 85
PDF
Rationale and design of the EMBRACE STEMI Study: A phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction
2013 · Anjan K. Chakrabarti, Kristin Feeney, et al. · American Heart Journal · 80
Increased asymmetric dimethylarginine and endothelin 1 levels in secondary Raynaud's phenomenon: Implications for vascular dysfunction and progression of disease
2003 · Sanjay Rajagopalan, Dana Pfenninger, et al. · Arthritis & Rheumatism · 70
PDF
Admission Hyperglycemia and Acute Myocardial Infarction: Outcomes and Potential Therapies for Diabetics and Nondiabetics
2012 · Anjan K. Chakrabarti, Priyamvada Singh, et al. · Cardiology Research and Practice · 23
PDF
The SYNTAX score: usefulness, limitations, and future directions.
2011 · Anjan K Chakrabarti, C Michael Gibson · PubMed · 21
Fatal or Irreversible Bleeding and Ischemic Events With Rivaroxaban in Acute Coronary Syndrome
2018 · C. Michael Gibson, Bennett Levitan, et al. · Journal of the American College of Cardiology · 18
307 Mechanical Circulatory Support for Right Ventricular Failure: The TandemHeart in RIght VEntricular Support (THRIVE) Registry
2012 · N.K. Kapur, V. Paruchuri, et al. · The Journal of Heart and Lung Transplantation · 16
Angiographic Validation of the American College of Cardiology Foundation–The Society of Thoracic Surgeons Collaboration on the Comparative Effectiveness of Revascularization Strategies Study
2014 · Anjan K. Chakrabarti, Maria V. Grau-Sepulveda, et al. · Circulation Cardiovascular Interventions · 15
Door-to-unload: Left Ventricular Unloading Before Reperfusion in ST-elevation Myocardial Infarction
2021 · Malav J Parikh, Karl H Schuleri, et al. · Future Cardiology · 13
Optimal selection of STEMI treatment strategies in the current era
2012 · Anjan K. Chakrabarti, C. Michael Gibson, et al. · Current Opinion in Cardiology · 8
Interactive effects of the ACE DD polymorphism with the NOS III homozygous G849T (Glu298→Asp) variant in determining endothelial function in coronary artery disease
2003 · Michael A Schmidt, Anjan K Chakrabarti, et al. · Vascular Medicine · 5
Utility of a real‐time appropriate use criteria decision support application for percutaneous coronary interventions in non‐acute coronary syndrome
2015 · Stuart H. Chen, Kalon K.L. Ho, et al. · Catheterization and Cardiovascular Interventions · 2
Abstract 13152: A Net Clinical Outcome Analysis Comparing Fatal or Irreversible Ischemic and Bleeding Events in ATLAS ACS 2 - TIMI 51
2012 · C. Michael Gibson, Bennett Levitan, et al. · Circulation · 2
Interactive effects of the ACE DD polymorphism with the NOS III homozygous G849T (Glu298-Asp) variant in determining endothelial function in coronary artery disease
2003 · Michael A. Schmidt, Anjan Chakrabarti, et al. · Journal of the American College of Cardiology · 1
Yoga, Neo-liberal Society, and Well-Being Industries: An Exploration of Global and Indian Perspectives
2026 · Anjan Chakrabarti · Springer eBooks
Poverty, Livelihood Insecurity and Food Crisis in the Global South: Mapping the Challenges of Sustainable Development Goals 1 and 2 and Prescribing Sustainable Solutions
2026 · Abinash Rai, Vaskar Barman, et al. · Springer eBooks
Abstract 038: American Heart Association Mission: Lifeline Breakthrough Series Collaborative Improving the Survival Rates for Out of Hospital Cardiac Arrest by Focusing on Early CPR With an Emphasis on Chest Compressions
2017 · Charles R Siegel, Anjan Chakrabarti, et al. · Circulation Cardiovascular Quality and Outcomes
Percutaneous coronary intervention of culprit and non-culprit coronary arteries in acute ST-elevation MI may improve outcomes
2014 · Stuart H Chen, Anjan K Chakrabarti · BMJ Evidence-Based Medicine
Works count: 32
Citation count: 1,411
H-index: 15
I10-index: 16
Year
Topic
Type